Sanofi, GSK get nod for phase 3 trial of covid-19 vaccine in India

This will be the first global trial for a foreign covid-19 vaccine to be conducted in India.In India, the pharma majors plan to recruit 3,000 participants across three trial sites in Ahmedabad, Jaipur and Hyderabad

from mint - Science https://ift.tt/3qSnAkp
https://ift.tt/eA8V8J